Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Agenus Inc (AGEN)

Agenus Inc (AGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 63,808
  • Shares Outstanding, K 23,459
  • Annual Sales, $ 156,310 K
  • Annual Income, $ -245,760 K
  • EBIT $ -114 M
  • EBITDA $ -100 M
  • 60-Month Beta 1.39
  • Price/Sales 0.42
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 170.06% ( -60.32%)
  • Historical Volatility 80.59%
  • IV Percentile 78%
  • IV Rank 29.24%
  • IV High 452.62% on 11/12/24
  • IV Low 53.32% on 01/18/24
  • Put/Call Vol Ratio 6.55
  • Today's Volume 702
  • Volume Avg (30-Day) 695
  • Put/Call OI Ratio 0.05
  • Today's Open Interest 56,648
  • Open Int (30-Day) 62,562

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -1.98
  • Number of Estimates 4
  • High Estimate 0.58
  • Low Estimate -2.89
  • Prior Year -2.60
  • Growth Rate Est. (year over year) +23.85%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.52 +4.31%
on 11/18/24
4.65 -43.44%
on 10/21/24
-1.99 (-43.07%)
since 10/18/24
3-Month
2.52 +4.31%
on 11/18/24
6.53 -59.72%
on 09/17/24
-2.65 (-50.19%)
since 08/16/24
52-Week
2.52 +4.31%
on 11/18/24
19.69 -86.64%
on 06/04/24
-11.17 (-80.94%)
since 11/17/23

Most Recent Stories

More News
Agenus (AGEN) Q3 2024 Earnings Call Transcript

AGEN earnings call for the period ending September 30, 2024.

AGEN : 2.63 (-3.31%)
Agenus: Q3 Earnings Snapshot

Agenus: Q3 Earnings Snapshot

AGEN : 2.63 (-3.31%)
Agenus (AGEN) Q2 2024 Earnings Call Transcript

AGEN earnings call for the period ending June 30, 2024.

AGEN : 2.63 (-3.31%)
Agenus: Q2 Earnings Snapshot

Agenus: Q2 Earnings Snapshot

AGEN : 2.63 (-3.31%)
3 Magnificent Growth Stocks to Buy Hand Over Fist

Small-cap stocks could get a boost from the central bank's anticipated rate cuts in 2025. These three stocks may be a great way to get ahead of this catalyst.

LGND : 111.67 (-0.04%)
AGEN : 2.63 (-3.31%)
CGC : 3.79 (+1.61%)
CURLF : 2.1700 (-2.25%)
Agenus (AGEN) Q1 2024 Earnings Call Transcript

AGEN earnings call for the period ending March 31, 2024.

AGEN : 2.63 (-3.31%)
Agenus: Q1 Earnings Snapshot

Agenus: Q1 Earnings Snapshot

AGEN : 2.63 (-3.31%)
Up 40%: Is This Red-Hot Growth Stock Still a Buy?

This small-cap biotech stock is surging. Time to buy?

AGEN : 2.63 (-3.31%)
Down 75%. Is Agenus Stock a Buy on the Dip?

Wall Street analysts who watch the cancer drug developer closely think it could rocket higher.

RILY : 4.60 (-2.54%)
MRK : 96.56 (+0.26%)
BMY : 56.80 (+1.03%)
GSK : 33.69 (+1.02%)
AGEN : 2.63 (-3.31%)
2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now?

These stocks could rocket higher, but they also present significant risks.

BMY : 56.80 (+1.03%)
GSK : 33.69 (+1.02%)
RILY : 4.60 (-2.54%)
DNA : 6.33 (-0.63%)
AGEN : 2.63 (-3.31%)

Business Summary

Agenus Inc., formerly known as Antigenics Inc., is engaged in the discovery, development and commercialization of immunotherapeutics for the treatment of life threatening and chronic medical conditions. Immunotherapeutics are drugs that work by modulating the immune system to fight diseases. The Company's...

See More

Key Turning Points

3rd Resistance Point 3.21
2nd Resistance Point 3.05
1st Resistance Point 2.84
Last Price 2.63
1st Support Level 2.47
2nd Support Level 2.31
3rd Support Level 2.10

See More

52-Week High 19.69
Fibonacci 61.8% 13.13
Fibonacci 50% 11.10
Fibonacci 38.2% 9.08
Last Price 2.63
52-Week Low 2.52

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar